Metastatic Breast Cancer
News
Biomarker testing in metastatic breast cancer management: ‘Essential’
Defining a breast tumor can be tricky because these cancers often don’t fit neatly into predefined categories.
Conference Coverage
Many patients, doctors unaware of advancements in cancer care
“These patients must be spared the traumatic effects of being handed a death sentence that no longer reflects the current reality,” said Dr....
News
Novel trastuzumab duocarmazine significantly improved survival in advanced HER2-positive breast cancer
Trastuzumab duocarmazine is a novel HER2-targeting antibody-drug conjugate which, according to the results of the TULIP trial recently presented...
Conference Coverage
Treatment shows 'important improvements' in triple-negative breast cancer
Survival of patients without an initial diagnosis of triple-negative breast cancer was better with the antibody-drug conjugate, compared with...
News
Better survival with extended letrozole in early-stage breast cancer
Guidelines for duration of endocrine therapy ‘should be updated.’
Conference Coverage
Most community-based oncologists skip biomarker testing
Survey shows that 48% of community clinicians use biomarker testing to guide treatment decisions, compared with 73% of academic clinicians.
Conference Coverage
Twelve-month overall survival benefit with ribociclib for metastatic breast cancer
It’s the first phase 3 trial to report a median overall survival beyond 5 years in advanced breast cancer.
News
Flurry of cancer drug endorsements from EU panel
Approvals include pralsetinib for non-small cell lung cancer, ripretinib for advanced gastrointestinal stromal tumor, and zanubrutinib for...
News
Immunotherapy for cancer patients with poor PS needs a rethink
Patients should not receive immunotherapy just to reduce risk of side effects, doctor says.
News
A case is building for personalized, genome-based radiation dosing
The data so far “seem very solid. I’m very excited by the concept,” Dr. Brian Marples said.